Shilpa Medicare Limited has published a postal ballot notice seeking shareholder approval for shifting its registered office from Karnataka to Maharashtra. The company’s board approved the proposal on May 22, 2026. The resolution seeks approval for the inter-state relocation and the alteration of the situation clause of the Memorandum of Association.

The proposed relocation involves moving the registered office from Raichur, Karnataka, to Office No. 1, “A” Wing, Ground Floor, Trade Star Building, J.B. Nagar, Andheri – Kurla Road, Andheri (East), Mumbai -400059, Maharashtra. The company stated that the shift is driven by business and administrative considerations, citing better access to financial institutions, regulatory authorities, and stakeholders in Mumbai.

Financial Results

Alongside the postal ballot process, the company announced its standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. For the standalone results, total income from operations for the year ended March 31, 2026, stood at Rs. 59,703 lakh, compared to Rs. 47,741 lakh in the previous year. The net profit after tax for the year was Rs. 13,297 lakh, up from Rs. 6,789 lakh in the previous year. The Board has recommended a final dividend of Rs. 0.60 per equity share for the financial year 2025-26.

Postal Ballot and E-Voting Details

In compliance with SEBI (LODR) Regulations, the company has restricted the voting process to remote e-voting only. Physical postal ballot forms will not be dispatched. The notice was published in Business Line and Saddi Moola newspapers on May 23, 2026. The notice and e-voting instructions have been sent electronically to members whose email addresses are registered with the Registrar and Share Transfer Agent, KFin Technologies Limited, or depositories as of the cut-off date of May 15, 2026.

Resolution and Scrutiny

The special resolution requires approval for the inter-state shift. Mr. Santosh Kumar Gunemoni has been appointed as the Scrutinizer. The results of the e-voting will be announced on or before June 24, 2026, and will be displayed on the company’s website and stock exchange platforms. Shareholders holding shares in physical or electronic form as on the cut-off date are eligible to vote.

Shilpa Medicare has announced its audited consolidated financial results for the quarter and year ended March 31, 2026. The company reported a significant turnaround in its financial performance, with consolidated net profit for Q4 FY26 rising to ₹10,779 lakhs compared to ₹1,451 lakhs in the corresponding quarter of the previous year. Following the earnings announcement, the audio recording of the Q4 FY26 earnings conference call held on May 22, 2026, has been uploaded to the company's website.

Q4 Consolidated Financial Performance

The table below summarizes the key consolidated financial metrics for the fourth quarter:

Revenue from operations for the quarter stood at ₹43,699 lakhs, a substantial increase from ₹33,082 lakhs in the prior year. The company's profit before tax also saw a sharp rise, reaching ₹12,045 lakhs in Q4 FY26 compared to ₹1,527 lakhs in Q4 FY25. Consequently, the net profit for the quarter attributable to owners of the parent company grew to ₹10,779 lakhs.

Annual Performance and Dividend

For the full financial year ended March 31, 2026, the company reported a consolidated net profit of ₹24,333 lakhs, compared to ₹7,829 lakhs in the previous year. Total revenue from operations for the year increased to ₹153,887 lakhs from ₹128,643 lakhs in FY25.

The Board of Directors has recommended a final dividend of ₹0.60 per equity share of face value ₹1 each for the financial year 2025-26. This dividend is subject to approval by the shareholders at the ensuing Annual General Meeting.

Corporate Developments

In addition to the financial results, the Board approved several key corporate actions. The company appointed M/s. V.J. Talati & Co. as Cost Auditors and M/s. Aneja Associates as Internal Auditors for FY 2026-27. Furthermore, the Board approved the shifting of the registered office from Karnataka to Maharashtra, subject to shareholder approval via postal ballot.

The company also announced that its wholly owned subsidiaries will make an equity investment of 28% in Neo Green Power Project Private Limited for captive power consumption. The acquisition is expected to be completed on or before June 15, 2026.